Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02BBA
|
||||
| Former ID |
DIB019822
|
||||
| Drug Name |
EPZ005687
|
||||
| Synonyms |
EPZ-005687; EPZ 005687
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [532062] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C32H37N5O3
|
||||
| InChI |
InChI=1S/C32H37N5O3/c1-21-15-22(2)35-32(39)28(21)18-33-31(38)27-16-25(17-30-29(27)19-34-37(30)26-5-3-4-6-26)24-9-7-23(8-10-24)20-36-11-13-40-14-12-36/h7-10,15-17,19,26H,3-6,11-14,18,20H2,1-2H3,(H,33,38)(H,35,39)
|
||||
| InChIKey |
ZOIBZSZLMJDVDQ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Enhancer of zeste homolog 2 | Target Info | Inhibitor | [532062] | |
| KEGG Pathway | MicroRNAs in cancer | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| WikiPathways | Interactome of polycomb repressive complex 2 (PRC2) | ||||
| Endoderm Differentiation | |||||
| Integrated Pancreatic Cancer Pathway | |||||
| Histone Modifications | |||||
| Cell Differentiation - meta | |||||
| miRs in Muscle Cell Differentiation | |||||
| miR-targeted genes in muscle cell - TarBase | |||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| miR-targeted genes in epithelium - TarBase | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.